Network Insights Methodology Whitepaper Get Access

AstraZeneca

ORG Health Care / Pharmaceuticals Momentum 7.8ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

$81.3B market cap (London-listed) AstraZeneca advanced label expansions for Imfinzi (checkpoint inhibitor) and Tremfya (psoriasis treatment) while pursuing salvage pathways for a failed antibody candidate. Active in oncology, immunology, and rare disease markets across 100+ countries.

Label expansions for oncology assets Imfinzi and Tremfya; evaluating alternative development pathways for failed antibody program.
-0.53
PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.
7.8
MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.
1%
ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.
17
ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.
AstraZeneca is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Connected Entities
FDA European Union PlocamiumAI China Eli Lilly Merck Pfizer Novartis Europe Sanofi United Kingdom Paris Supreme Court Alphabet Yahoo
Watch This Entity
PSI Intelligence
30-Day Trend
2026-05-14 2026-06-13 17 0 Degree Mentions
Signal Decomposition
Attention Cascade
0.236
Narrative Drift
0.000
Spectral Shift
407.175
Sentiment-Momentum Divergence
0.000
Source Concentration
0.497
Signal
AstraZeneca is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).
Driver
Ranked #87 of 90 in Health Care — unusually quiet vs peers (-2.2 sigma below). PSI up 0.60 from yesterday (-1.13 -> -0.53).
Action
Baseline conditions. Continue standard monitoring cadence.
Peer Comparison
87 of 90
Sector Rank
-2.24
Peer Z-Score
3%
Sector Percentile
Network Analysis
17 Degree Centrality
Ego Network (top connections)
FDA (weight 29.0)European Union (weight 11.0)PlocamiumAI (weight 10.0)China (weight 8.0)Eli Lilly (weight 7.0)Merck (weight 7.0)Pfizer (weight 6.0)Novartis (weight 4.0) FDAEuropean UnionPlocamiumAIChinaEli LillyMerckPfizerNovartis AstraZeneca (degree 17) AstraZeneca
Centrality History
2026-05-14 2026-06-13 17 0 Degree Mentions
EntityWeight StatusFirst Seen
FDA 29 NEW
European Union 11 NEW
PlocamiumAI 10 NEW
China 8 NEW
Eli Lilly 7 NEW
Merck 7 NEW
Pfizer 6 NEW
Novartis 4 NEW
Europe 4 NEW
Sanofi 4 NEW
United Kingdom 3 NEW
Paris 3 NEW
Supreme Court 3 NEW
Alphabet 2 NEW
Yahoo 2 NEW
Florida 2 NEW
Chief 1 NEW
Article Coverage (0)
DateLaneTitle
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-06-13 ← Intelligence Network